Pfizer Inc
NYSE: PFE
$26.59
-$0.02 (-0.1%)
Closing Price on January 3, 2025
PFE Articles
After U.S. markets closed on Thursday, Ford beat estimates on both the top and bottom lines, posting a 12% year-over-year increase in revenue and a 5.9% increase in earnings per share (EPS). And even...
Published:
These seven big-dividend stocks offer growth if the market continues higher, but also a degree of safety if the AI-driven bubble bursts and market declines and volatility return, as J.P. Morgan warns...
Published:
Friday's top analyst upgrades and downgrades included Citizens Financial, Eaton, Freeport-McMoRan, General Mills, Graphic Packaging, Micron Technology, Mosaic, Netflix, Pfizer, Roku, Ross Stores and...
Published:
With money market and certificate of deposit rates over 4% and interest rate hikes winding down, it makes sense now for growth and income investors to look at blue chip stocks with big and dependable...
Published:
Friday's top analyst upgrades and downgrades included Albemarle, Alcoa, Alphabet, Block, CF Industries, Kraft Heinz, Livent, Mosaic, Norfolk Southern, Pfizer, RingCentral, Roblox, StoneCo, Trade...
Published:
Before U.S. markets open on Tuesday, these four companies are scheduled to release quarterly earnings reports.
Published:
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Published:
Monday's top analyst upgrades and downgrades included Altria, Block, Coinbase Global, Deere, First Horizon, KB Home, Pfizer, PNC Financial Services, RingCentral, Uber Technologies znd Zoom Video...
Published:
Top Wall Street strategists are stressing that value remains the best place to be until the final bottom for the bear market is seen. Here are seven dividend-paying value stocks that should hold up...
Published:
The U.S. Treasury Department and the Federal Reserve took decisive steps to prevent the collapse of two banks from turning into a bank run. Equities were showing some positive effects early Monday.
Published:
Tuesday's top analyst upgrades and downgrades included Altria, Apple, D.R. Horton, Equitrans Midstream, Fortinet, General Electric, Nextracker, Palo Alto Networks, Pfizer, Silvergate Capital, Tesla...
Published:
Warren Buffett's annual letter, Bed Bath & Beyond's latest lease on life and a possible pharma deal worth more than $30 billion.
Published:
Wednesday's top analyst upgrades and downgrades included Alcoa, Cloudflare, Foot Locker, Fortinet, Lockheed Martin, On Semiconductor, Ovintiv, Pfizer, Take-Two Interactive Software, Tyson Foods and...
Published:
Five companies, including three Dow Jones industrials, are on deck to report quarterly earnings before markets open on Tuesday.
Published:
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.
Published: